Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: Two randomized controlled trials

Journal of Acquired Immune Deficiency Syndromes

Volumn 65, Issue 2, 2014, Pages 198-206

  Denoeud Ndam, Lise ^a,b   Zannou, Djimon Marcel ^c,d   Fourcade, Camille ^a,b   Taron Brocard, Clément ^a,b   Porcher, Raphaël ^e   Atadokpede, Felix ^f   Komongui, Didier G ^g   Dossou Gbete, Lucien ^h   Afangnihoun, Aldric ⁱ   Ndam, Nicaise T ^a,b   Girard, Pierre Marie ^j,k   Cot, Michel ^a,b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Centre National Hospitalier Universitaire Hubert Koutoukou Maga   (Benin)

^d UNIVERSITY OF ABOMEY CALAVI   (Benin)

^e SAINT LOUIS HOSPITAL   (France)

^f Service d hépato gastroentérologie Hôpital d Instruction des Armées   (Benin)

^g Hopital de la Mere et de l'Enfant Lagune   (Benin)

^h Clinique Louis Pasteur   (Benin)

ⁱ Centre de Traitement Ambulatoire   (Benin)

^j HÔPITAL SAINT ANTOINE   (France)

^k INSERM   (France)

more..

Author keywords

Cotrimoxazole; HIV; Malaria during pregnancy; Mefloquine; Randomized controlled trial

Indexed keywords

COTRIMOXAZOLE; MEFLOQUINE;

ADULT; ANEMIA; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; GASTROENTERITIS; GENITAL TRACT INFECTION; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPENIA; MALARIA; MALARIA CONTROL; NAUSEA; OPEN STUDY; PAIN; PARASITEMIA; POLYMERASE CHAIN REACTION; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERAL PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SOMNOLENCE; THROMBOCYTOPENIA; TUBERCULOUS PLEURISY; UTERUS RUPTURE; VOMITING; WASTING SYNDROME; YOUNG ADULT;

ADULT; ANTIMALARIALS; BENIN; CHEMOPREVENTION; DIZZINESS; DRUG THERAPY, COMBINATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; MEFLOQUINE; PARASITEMIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; YOUNG ADULT;

EID: 84893723019     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000058     Document Type: Article

References (42)

1. Abu-Raddad LJ, Patnaik P, Kublin JG. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. Science. 2006;314:1603-1606.
2. Ladner J, Leroy V, Karita E, et al. Malaria, HIV and pregnancy. AIDS. 2003;17:275-276.
3. Perrault SD, Hajek J, Zhong K, et al. Human immunodeficiency virus coinfection increases placental parasite density and transplacental malaria transmission in Western Kenya. Am J Trop Med Hyg. 2009;80:119-125.
4. van Eijk AM, Ayisi JG, ter Kuile FO, et al. HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya. AIDS. 2003;17: 595-603.
5. Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis. 2000;181:1740-1745.
6. Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev. 2004;17:760-769.
7. Steketee RW. Malaria prevention in pregnancy: when will the prevention programme respond to the science. J Health Popul Nutr. 2002;20:1-3.
8. Bulterys PL, Chao A, Dalai SC, et al. Placental malaria and mother-tochild transmission of human immunodeficiency virus-1 in rural Rwanda. Am J Trop Med Hyg. 2011;85:202-206.
9. Kourtis AP, Bulterys M, Nesheim SR, et al. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285:709-712.
10. WHO. Malaria and HIV/AIDS Interactions and Their Implications for Public Health Policies. Geneva, Switzerland: WHO; 2004.
11. Thera MA, Sehdev PS, Coulibaly D, et al. Impact of trimethoprimsulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis. 2005;192:1823-1829.
12. Newman PM, Wanzira H, Tumwine G, et al. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J. 2009;8:254.
13. Kapito-Tembo A, Meshnick SR, van Hensbroek MB, et al. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxinepyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis. 2011;203:464-472.
14. Manyando C, Njunju EM, D'Alessandro U, et al. Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One. 2013;8:e56916.
15. Ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297: 2603-2616.
16. Mathanga DP, Uthman OA, Chinkhumba J. Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women. Cochrane Database Syst Rev. 2011;10:CD006689.
17. Challis K, Osman NB, Cotiro M, et al. Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Trop Med Int Health. 2004;9:1066-1073.
18. Kayentao K, Kodio M, Newman RD, et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis. 2005;191:109-116.
19. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine- pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg. 1998;59:813-822.
20. Shulman CE, Dorman EK, Cutts F, et al. Intermittent sulphadoxinepyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet. 1999;353: 632-636.
21. Hamer DH, Mwanakasale V, Macleod WB, et al. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxinepyrimethamine in HIV-seropositive pregnant Zambian women. J Infect Dis. 2007;196:1585-1594.
22. Filler SJ, Kazembe P, Thigpen M, et al. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. J Infect Dis. 2006;194:286-293.
23. WHO. A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. Brazzaville, Congo: WHO Regional Office for Africa; 2004.
24. Briand V, Bottero J, Noel H, et al. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis. 2009;200:991-1001.
25. Akogbeto M, Modiano D, Bosman A. Malaria transmission in the lagoon area of Cotonou, Benin. Parasitologia. 1992;34:147-154.
26. UNAIDS. UNAIDS Report on the Global AIDS Epidemic 2012. Geneva, Switzerland: UNAIDS; 2012.
27. Denoeud-Ndam L, Fourcade C, Ogouyemi-Hounto A, et al. Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin. PLoS One. 2013;8:e59446.
28. Diallo A, Ndam NT, Moussiliou A, et al. Asymptomatic carriage of plasmodium in urban Dakar: the risk of malaria should not be underestimated. PLoS One. 2012;7:e31100.
29. Agence Nationale de Recherche contre le Sida. Echelle ANRS de Cotation de la Gravité des Evénements Indésirables chez l'adulte. Version n 6 du 9 septembre. 2003. Available at: http://www.anrs.fr/ Rubriquestransversales/ Outils-pour-la-recherche. Accessed October 27, 2013.
30. Lawn JE, Blencowe H, Pattinson R, et al. Stillbirths: where? When? Why? How to make the data count? Lancet. 2011;377:1448-1463.
31. Ekouevi DK, Coffie PA, Ouattara E, et al. Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2011;56:183-187.
32. Marazzi MC, Palombi L, Nielsen-Saines K, et al. Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes. AIDS. 2011;25:1611-1618.
33. French N, Nakiyingi J, Lugada E, et al. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. AIDS. 2001;15:899-906.
34. Whitworth J, Morgan D, Quigley M, et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet. 2000;356:1051-1056.
35. Campbell JD, Moore D, Degerman R, et al. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts .200 cells/mL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea. Clin Infect Dis. 2012;54:1204-1211.
36. Kublin JG, Dzinjalamala FK, Kamwendo DD, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380-388.
37. Duah NO, Quashie NB, Abuaku BK, et al. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxinepyrimethamine 5 years after the change of malaria treatment policy in Ghana. Am J Trop Med Hyg. 2012;87:996-1003.
38. Briand V, Cottrell G, Massougbodji A, et al. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J. 2007;6:160.
39. Denoeud-Ndam L, Clement MC, Briand V, et al. Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin. J Acquir Immune Defic Syndr. 2012;61:64-72.
40. Schlagenhauf P, Blumentals WA, Suter P, et al. Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy. Clin Infect Dis. 2012;54:e124-e131.
41. Namusoke F, Ntale M, Wahlgren M, et al. Validity of self-reported use of sulfadoxine-pyrimethamine intermittent presumptive treatment during pregnancy (IPTp): a cross-sectional study. Malar J. 2012;11:310.
42. WHO. Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. PRogrammatic Update. Geneva, Switzerland: WHO; 2012.